A Phase I, Pharmacokinetic and Tolerability Study of Intravenous Unfractionated Heparin After Subcutaneous Enoxaparin [enoxaparin sodium] 1mg/kg Bid Repeated Administration in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 14 Mar 2011
At a glance
- Drugs Enoxaparin sodium; Heparin
- Indications Thrombosis
- Focus Pharmacodynamics
- Acronyms STACKENOX
- Sponsors Sanofi
- 14 Mar 2011 Last checked against ClinicalTrials.gov record.
- 01 Aug 2009 Results published in the American Heart Journal.
- 03 Sep 2008 Results of this study was published in the proceedings of the ESC Congress 2008: Annual Congress of the European Society of Cardiology.